Market Value1,538,535,000
Total Holdings65
File Date2018-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
US62857M1053 / MyoKardia, Inc.
CLSD / Clearside Biomedical, Inc.
NKTR / Nektar Therapeutics Call
DRNA / Dicerna Pharmaceuticals Inc
ITRM / Iterum Therapeutics plc
NERV / Minerva Neurosciences, Inc.
NKTR / Nektar Therapeutics
ARQL / ArQule, Inc.
ZGNX / Zogenix Inc
ZGNX / Zogenix Inc Call
GTHX / G1 Therapeutics, Inc.
CLRBW / Cellectar Biosciences, Inc. Warrants expiring 8/20/2019
RUBY / Rubius Therapeutics, Inc.
TSRO / TESARO, Inc. Call
BOLD / Boundless Bio, Inc.
TSRO / TESARO, Inc.
INCY / Incyte Corporation
SGMO / Sangamo Therapeutics, Inc.
VNDA / Vanda Pharmaceuticals Inc.
QTRX / Quanterix Corporation
ONSIW / Oncobiologics, Inc. Series A Warrant Expiring 2/18/2018
US00972L1070 / Akcea Therapeutics Inc. Put
TBIO / Telesis Bio, Inc.
AVRO / AVROBIO, Inc.
GEMP / Gemphire Therapeutics Inc.
IL0011177958 / Intec Pharma Ltd
SPPI / Spectrum Pharmaceuticals, Inc.
TCDA / Tricida Inc
QTNT / Quotient Ltd
TRIL / Trillium Therapeutics Inc
RETA / Reata Pharmaceuticals Inc - Class A
INSP / Inspire Medical Systems, Inc.
ARNA / Arena Pharmaceuticals Inc
US28249H1041 / Eidos Therapeutics, Inc.
US74257L1089 / Principia Biopharma Inc.
KZR / Kezar Life Sciences, Inc.
CFRX / ContraFect Corp
SRRK / Scholar Rock Holding Corporation
IFRX / InflaRx N.V.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
TBPH / Theravance Biopharma, Inc.
COLL / Collegium Pharmaceutical, Inc.
/ Array BioPharma, Inc.
ACRS / Aclaris Therapeutics, Inc.
US2103731061 / Constellation Pharmaceuticals Inc
KNSA / Kiniksa Pharmaceuticals, Ltd.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
SLDB / Solid Biosciences Inc.
NBIX / Neurocrine Biosciences, Inc.
MRNS / Marinus Pharmaceuticals, Inc.
ANAB / AnaptysBio, Inc.
XLRN / Acceleron Pharma Inc
HRTX / Heron Therapeutics, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
PTGX / Protagonist Therapeutics, Inc.
MRTX / Mirati Therapeutics, Inc.
BPMC / Blueprint Medicines Corporation
SAGE / Sage Therapeutics, Inc.
ABEO / Abeona Therapeutics Inc.
MGTX / MeiraGTx Holdings plc
REPL / Replimune Group, Inc.
YMAB / Y-mAbs Therapeutics, Inc.
OMER / Omeros Corporation
RCKT / Rocket Pharmaceuticals, Inc.
OMER / Omeros Corporation Call
APLS / Apellis Pharmaceuticals, Inc.
BHVN / Biohaven Ltd.